The DYNLT3 Knockout A-549 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout population derived from the A-549 human lung adenocarcinoma epithelial line. This heterogeneous pool of DYNLT3-disrupted cells avoids clonal selection artifacts and preserves genetic diversity, providing a robust system for bulk population analyses of dynein light chain functions.
A-549 cells, established from a human lung adenocarcinoma, exhibit adherent epithelial morphology and are a standard model for lung cancer biology. They support investigations of oncogenic signaling, tumor migration, and drug response, while their epithelial character enables studies of polarity, junctions, and ciliogenesis in a reproducible, gene-editing-compatible system.
DYNLT3 encodes a dynein light chain that integrates into the cytoplasmic dynein motor complex alongside the heavy chain DYNC1H1 and the dynactin subunit DCTN1. This complex mediates minus-end-directed transport of diverse cargoes along microtubules. DYNLT3 directly interacts with cargo adaptors such as BICD2 and HOOK3 to orchestrate retrograde trafficking of endosomes, lysosomes, and mitotic proteins. Upstream, DYNLT3 expression is regulated by RFX transcription factors and FOXJ1, master regulators of ciliary gene expression, while cell cycle regulators further modulate its activity. Downstream, dynein-mediated transport is essential for accurate mitotic spindle positioning and for delivering hedgehog pathway components, including GLI transcription factors, to the primary cilium. Thus, DYNLT3 serves as a critical interface between extracellular signaling and intracellular motility, with implications for ciliogenesis and cell division.
In A-549 lung adenocarcinoma cells, DYNLT3 knockout disrupts dynein-dependent retrograde transport, impairing timely delivery of endosomal cargoes and mitotic regulators. This leads to defective mitotic spindle assembly, chromosomal instability, and altered cell proliferation. Additionally, failure to recycle endosomal receptors attenuates downstream signaling pathways, reducing migratory and invasive potential. Given the established role of dynein in ciliary trafficking, DYNLT3 disruption likely compromises ciliogenesis, thereby dampening hedgehog pathway activity??a pathway frequently dysregulated in lung cancer. Consequently, these polyclonal knockout cells constitute a physiologically relevant model to investigate how dynein dysfunction contributes to genomic instability, migration defects, and aberrant signal transduction in lung adenocarcinoma progression.
These polyclonal knockout cells are suited for a wide range of experimental assays. Researchers can validate DYNLT3 disruption using western blotting, RT-qPCR, and immunofluorescence. Functional characterization may involve live-cell imaging to monitor organelle motility defects, co-immunoprecipitation to map disrupted dynein?Cadaptor interactions (e.g., with BICD2 or HOOK3), and immunofluorescence-based mitotic spindle visualization to quantify positioning errors. Migration and invasion assays can assess motility changes, while cell cycle analysis reveals proliferation and mitotic progression defects. Together, these applications enable detailed dissection of DYNLT3??s roles in intracellular transport, mitosis, and ciliogenesis within a lung cancer context. For further technical information, please contact Ascent Research.
